While the study establishes BTK as an upstream regulator of cGAS-STING-NF-κB signaling, the precise molecular mechanisms by which BTK integrates multiple inflammatory inputs to selectively activate this pathway remain unclear. This mechanistic gap limits understanding of how to precisely modulate neuroinflammation in ALS. Gap type: unexplained_observation Source paper: BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis. (2026, Brain : a journal of neurology, PMID:41710977)
Landscape Summary: How does BTK integrate DNA-sensing and TLR signals to specifically activate the cGAS-STING pathway in ALS? is a 0.77 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How does BTK integrate DNA-sensing and TLR signals to specifically activate the cGAS-STING pathway in ALS? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: